SCHEMBL31245871

SCHEMBL31245871

CC(C)OC(=O)CCCN(CCCN)CCCC(=O)OC(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
CYP1A2 P05177 1/20 0.40
MAPT P10636 3/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
ALDH1A1 P00352 5/20 0.34
GAA P10253 1/20 0.34
EPHX2 P34913 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
P2RY12 Q9H244 1/20 0.34
HTT P42858 1/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 1/20 0.33
PAOX Q6QHF9 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31245913 0.88 LMNA (0.49) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL593286 0.85 LMNA (0.61) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL28864170 0.83 LMNA (0.64) LMNACYP1A2MAPTHSD17B10ALOX15
Hydrochloric Acid SCHEMBL10347010 0.83 LMNA (0.59) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL11266298 0.81 LMNA (0.68) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL18476686 0.81 LMNA (0.68) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL10081253 0.77 LMNA (0.57) LMNAMAPTHSD17B10ALOX15CASP1
Ethylenediamine SCHEMBL7702427 0.76 LMNA (0.54) LMNACYP1A2MAPTHSD17B10ALOX15
SCHEMBL7078022 0.76
SCHEMBL15391 0.76 LMNA (0.78) LMNACYP1A2MAPTHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP disclosed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO disclosed